search
Back to results

Study on Preliminary Safety and Efficacy of the ARC Therapy Using the ARC-IM Lumbar System to Support Mobility in People With Chronic Spinal Cord Injury (BoxSwitch) (BoxSwitch)

Primary Purpose

Spinal Cord Injuries

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Procedure/Surgery
Sponsored by
Ecole Polytechnique Fédérale de Lausanne
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Spinal Cord Injuries focused on measuring SCI, Spinal Cord Injury, Epidural Spinal Stimulation

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Having completed the main phase of the STIMO study (NCT02936453) and having improved on at least one of the primary or secondary endpoints (WISCI II Score, 10-Meter Walk test, Weight Bearing Capacity, SCIM III Score or 6-Minute Walk test). Age 18-65 SCI graded as American Spinal Injury Association Impairment Scale (AIS) A, B, C & D SCI ≥ 12months SCI lesion level T10 and above with preservation of conus function SCI due to trauma Stable medical, physical and psychological condition as considered by the investigators Able to understand and interact with the study team in French or English Agrees to comply in good faith with all conditions of the study and to attend all scheduled appointments Must provide and sign the Informed Consent prior to any study-related procedures Exclusion Criteria: Diseases and conditions that would increase the morbidity and mortality of spinal cord injury surgery History of myocardial infarction or cerebrovascular event within the past 6 months Limitation of walking function based on accompanying (CNS) disorders (systemic malignant disorders, cardiovascular disorders restricting physical training, peripheral nerve disorders) Any active implanted cardiac device such as pacemaker or defibrillator Any indication that would require diathermy Any indication that would require MRI Any anatomical limitations in the implantation area as judged by the investigators Other conditions that would make the subject unable to participate in testing in the judgement of the investigators Clinically significant mental illness in the judgement of the investigators Presence of indwelling baclofen or insulin pump Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.) Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, or dementia of the participant Enrolment of the investigator, his/her family members, employees, and other dependent persons

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Targeted Epidural Spinal Stimulation

    Arm Description

    Single arm study: the participants that have undergone the STIMO study will be proposed to exchange their currently implanted system with selected components from the ARC-IM Lumbar system. After the surgery, the participants will perform around 20 optimization sessions that may include rehabilitation to configure the neuromodulation system. Then the participants will use the ARC-IM Lumbar system independently during daily life activities until the end of the 36 months post-surgery. Assessments will be planned throughout the course of the study at the end of the optimization phase, after 12 and 24 months post-surgery and at the end of the study, with and/or stimulation.

    Outcomes

    Primary Outcome Measures

    Preliminary safety of the ARC Therapy
    Occurrence of Serious Adverse Events and Adverse Events that are deemed related or possibly related to the study procedure or to the ARC-IM system.

    Secondary Outcome Measures

    10 Meters Walk test (m/s)
    The 10 Meters Walk Test is a performance measure used to assess walking speed in meters per second over a short distance.
    6 Minutes Walk test (meters)
    The 6 minutes walk test is a performance measureused to assess aerobic capacity and endurance.
    International Standards For Neurological Classification of Spinal Injury (ISNCSCI)
    A neurological assessment and classification of a spinal cord injury
    Spinal Cord Injury Functional Ambulation Inventory (SCI-FAI)
    The SCI-FAI assesses functional walking ability in ambulatory individuals with SCI.
    Neuromuscular Recovery Scale (NRS)
    The NRS is used to measure quality of movement without compensatory movement patterns using a body weight support system and a treadmill.
    Walking Index for Spinal Cord Injury (WISCI II)
    The Walking Index for Spinal Cord Injury (WISCI) is a scale that measures the type and amount of assistance (in terms of requirements of assistive devices, or human helpers) required by a person with spinal cord injury (SCI) for walking.
    Modified Ashworth Scale (MAS)
    The modified Ashworth scale a universally accepted clinical tool used to measure the increase of muscle tone.
    Spinal Cord Independence Measure (SCIM III)
    The SCIM address specific areas of function in patients with spinal cord injuries (SCI).
    Quality of Life questionnaires
    Questionnaires addressing bowel, bladder and sexual functions.

    Full Information

    First Posted
    June 12, 2023
    Last Updated
    July 4, 2023
    Sponsor
    Ecole Polytechnique Fédérale de Lausanne
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05942339
    Brief Title
    Study on Preliminary Safety and Efficacy of the ARC Therapy Using the ARC-IM Lumbar System to Support Mobility in People With Chronic Spinal Cord Injury (BoxSwitch)
    Acronym
    BoxSwitch
    Official Title
    Study on Preliminary Safety and Efficacy of the ARC Therapy Using the ARC-IM Lumbar System to Support Mobility in People With Chronic Spinal Cord Injury
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    August 2023 (Anticipated)
    Primary Completion Date
    August 2027 (Anticipated)
    Study Completion Date
    August 2027 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Ecole Polytechnique Fédérale de Lausanne

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The purpose of this pre-market clinical study is to assess the preliminary safety and efficacy of the ARC Therapy using the ARC-IM Lumbar System at supporting mobility in participants with chronic spinal cord injury. Only participants that have undergone the STIMO study (NCT02936453) will be proposed to exchange their currently implanted system with components of the newly developed ARC-IM Lumbar system. The goal is to improve more effective lower-limb motor activities, while also simplifying the personal at-home use of the system. In addition, this study aims to evaluate the potential effect of ARC Therapy on muscle tone, bladder, bowel and sexual functions, and quality of life of the participants. Preliminary safety and efficacy will be assessed in both the short term and throughout the duration of the study (from the surgery to 36 months after the implantation of the ARC-IM Lumbar system).
    Detailed Description
    Studies have shown that using Electrical Epidural Stimulation (EES) could improve considerably the functional movements after paralyzing SCI. In the STIMO study (NCT02936453), the investigational system was mainly composed of medical devices developed for other indications and used off-label, allowing only a limited tuning of EES protocols. To overcome this limitation, we propose to conduct a study in which a new platform will be investigated. This new therapy, named ARC Therapy, features the ARC-IM implantable pulse generator with an optimized communication system and the ARC-IM implantable leads supporting stimulation protocols specifically developed for effective activation of motor neurons. The study will take place at the CHUV (Lausanne, Switzerland). A maximum of 8 participants will be enrolled in the study and implanted with an ARC-IM IPG. Only participants that have undergone the STIMO protocol (NCT02936453) can enrol in the current BoxSwitch study. Replacement of their currently implanted IPG and lead will be assessed on a case-by-case manner considering current status of their implanted devices, technical and surgical compatibility with the newly proposed ARC-IM Lumbar system components. The study intervention consists of several phases preceded by pre-screening: Screening and enrollment, baseline and pre-implantation assessments, surgery, optimization phase, short-term assessments, independent use phase and follow-up assessments at months 12, 24 and 36. Measures will be performed before surgical intervention and at regular intervals during the study. The total duration of the study will be approximately 48 months (up to 36 months/participant).

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Spinal Cord Injuries
    Keywords
    SCI, Spinal Cord Injury, Epidural Spinal Stimulation

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Model Description
    Single-site, single-arm, non-blinded, non-randomized, interventional
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    8 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Targeted Epidural Spinal Stimulation
    Arm Type
    Experimental
    Arm Description
    Single arm study: the participants that have undergone the STIMO study will be proposed to exchange their currently implanted system with selected components from the ARC-IM Lumbar system. After the surgery, the participants will perform around 20 optimization sessions that may include rehabilitation to configure the neuromodulation system. Then the participants will use the ARC-IM Lumbar system independently during daily life activities until the end of the 36 months post-surgery. Assessments will be planned throughout the course of the study at the end of the optimization phase, after 12 and 24 months post-surgery and at the end of the study, with and/or stimulation.
    Intervention Type
    Device
    Intervention Name(s)
    Procedure/Surgery
    Intervention Description
    The intervention involves the replacement of parts of the current implanted system with components of the ARC-IM Lumbar system.
    Primary Outcome Measure Information:
    Title
    Preliminary safety of the ARC Therapy
    Description
    Occurrence of Serious Adverse Events and Adverse Events that are deemed related or possibly related to the study procedure or to the ARC-IM system.
    Time Frame
    Through study completion (expected 3 years)
    Secondary Outcome Measure Information:
    Title
    10 Meters Walk test (m/s)
    Description
    The 10 Meters Walk Test is a performance measure used to assess walking speed in meters per second over a short distance.
    Time Frame
    Baseline, Short-term (up to 6months), 12 months, 24 months and 36 months
    Title
    6 Minutes Walk test (meters)
    Description
    The 6 minutes walk test is a performance measureused to assess aerobic capacity and endurance.
    Time Frame
    Baseline, Short-term (up to 6months), 12 months, 24 months and 36 months
    Title
    International Standards For Neurological Classification of Spinal Injury (ISNCSCI)
    Description
    A neurological assessment and classification of a spinal cord injury
    Time Frame
    Baseline, 12 months, 24 months and 36 months
    Title
    Spinal Cord Injury Functional Ambulation Inventory (SCI-FAI)
    Description
    The SCI-FAI assesses functional walking ability in ambulatory individuals with SCI.
    Time Frame
    Baseline, Short-term (up to 6months), 12 months, 24 months and 36 months
    Title
    Neuromuscular Recovery Scale (NRS)
    Description
    The NRS is used to measure quality of movement without compensatory movement patterns using a body weight support system and a treadmill.
    Time Frame
    Baseline, Short-term (up to 6months), 12 months, 24 months and 36 months
    Title
    Walking Index for Spinal Cord Injury (WISCI II)
    Description
    The Walking Index for Spinal Cord Injury (WISCI) is a scale that measures the type and amount of assistance (in terms of requirements of assistive devices, or human helpers) required by a person with spinal cord injury (SCI) for walking.
    Time Frame
    Baseline, Short-term (up to 6months), 12 months, 24 months and 36 months
    Title
    Modified Ashworth Scale (MAS)
    Description
    The modified Ashworth scale a universally accepted clinical tool used to measure the increase of muscle tone.
    Time Frame
    Baseline, Short-term (up to 6months), 12 months, 24 months and 36 months
    Title
    Spinal Cord Independence Measure (SCIM III)
    Description
    The SCIM address specific areas of function in patients with spinal cord injuries (SCI).
    Time Frame
    Baseline, Short-term (up to 6months), 12 months, 24 months and 36 months
    Title
    Quality of Life questionnaires
    Description
    Questionnaires addressing bowel, bladder and sexual functions.
    Time Frame
    Monthly during the first year

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Having completed the main phase of the STIMO study (NCT02936453) and having improved on at least one of the primary or secondary endpoints (WISCI II Score, 10-Meter Walk test, Weight Bearing Capacity, SCIM III Score or 6-Minute Walk test). Age 18-65 SCI graded as American Spinal Injury Association Impairment Scale (AIS) A, B, C & D SCI ≥ 12months SCI lesion level T10 and above with preservation of conus function SCI due to trauma Stable medical, physical and psychological condition as considered by the investigators Able to understand and interact with the study team in French or English Agrees to comply in good faith with all conditions of the study and to attend all scheduled appointments Must provide and sign the Informed Consent prior to any study-related procedures Exclusion Criteria: Diseases and conditions that would increase the morbidity and mortality of spinal cord injury surgery History of myocardial infarction or cerebrovascular event within the past 6 months Limitation of walking function based on accompanying (CNS) disorders (systemic malignant disorders, cardiovascular disorders restricting physical training, peripheral nerve disorders) Any active implanted cardiac device such as pacemaker or defibrillator Any indication that would require diathermy Any indication that would require MRI Any anatomical limitations in the implantation area as judged by the investigators Other conditions that would make the subject unable to participate in testing in the judgement of the investigators Clinically significant mental illness in the judgement of the investigators Presence of indwelling baclofen or insulin pump Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.) Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, or dementia of the participant Enrolment of the investigator, his/her family members, employees, and other dependent persons
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Grégoire Courtine, Prof
    Phone
    +41 21 69 30762
    Email
    gregoire.courtine@epfl.ch
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Jocelyne Bloch, MD
    Organizational Affiliation
    CHUV
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    15672628
    Citation
    Anderson KD. Targeting recovery: priorities of the spinal cord-injured population. J Neurotrauma. 2004 Oct;21(10):1371-83. doi: 10.1089/neu.2004.21.1371.
    Results Reference
    background
    PubMed Identifier
    23884034
    Citation
    Cragg JJ, Noonan VK, Krassioukov A, Borisoff J. Cardiovascular disease and spinal cord injury: results from a national population health survey. Neurology. 2013 Aug 20;81(8):723-8. doi: 10.1212/WNL.0b013e3182a1aa68. Epub 2013 Jul 24.
    Results Reference
    background
    PubMed Identifier
    29459943
    Citation
    West CR, Phillips AA, Squair JW, Williams AM, Walter M, Lam T, Krassioukov AV. Association of Epidural Stimulation With Cardiovascular Function in an Individual With Spinal Cord Injury. JAMA Neurol. 2018 May 1;75(5):630-632. doi: 10.1001/jamaneurol.2017.5055. Erratum In: JAMA Neurol. 2018 Dec 1;75(12):1575.
    Results Reference
    background
    PubMed Identifier
    26931074
    Citation
    Brinkhof MW, Al-Khodairy A, Eriks-Hoogland I, Fekete C, Hinrichs T, Hund-Georgiadis M, Meier S, Scheel-Sailer A, Schubert M, Reinhardt JD; SwiSCI Study Group. Health conditions in people with spinal cord injury: Contemporary evidence from a population-based community survey in Switzerland. J Rehabil Med. 2016 Feb;48(2):197-209. doi: 10.2340/16501977-2039.
    Results Reference
    background
    PubMed Identifier
    19406310
    Citation
    Krassioukov A, Eng JJ, Warburton DE, Teasell R; Spinal Cord Injury Rehabilitation Evidence Research Team. A systematic review of the management of orthostatic hypotension after spinal cord injury. Arch Phys Med Rehabil. 2009 May;90(5):876-85. doi: 10.1016/j.apmr.2009.01.009.
    Results Reference
    background
    PubMed Identifier
    30382196
    Citation
    Formento E, Minassian K, Wagner F, Mignardot JB, Le Goff-Mignardot CG, Rowald A, Bloch J, Micera S, Capogrosso M, Courtine G. Electrical spinal cord stimulation must preserve proprioception to enable locomotion in humans with spinal cord injury. Nat Neurosci. 2018 Dec;21(12):1728-1741. doi: 10.1038/s41593-018-0262-6. Epub 2018 Oct 31.
    Results Reference
    background
    PubMed Identifier
    25962761
    Citation
    Phillips AA, Krassioukov AV. Contemporary Cardiovascular Concerns after Spinal Cord Injury: Mechanisms, Maladaptations, and Management. J Neurotrauma. 2015 Dec 15;32(24):1927-42. doi: 10.1089/neu.2015.3903. Epub 2015 Sep 1.
    Results Reference
    background
    PubMed Identifier
    36352232
    Citation
    Kathe C, Skinnider MA, Hutson TH, Regazzi N, Gautier M, Demesmaeker R, Komi S, Ceto S, James ND, Cho N, Baud L, Galan K, Matson KJE, Rowald A, Kim K, Wang R, Minassian K, Prior JO, Asboth L, Barraud Q, Lacour SP, Levine AJ, Wagner F, Bloch J, Squair JW, Courtine G. The neurons that restore walking after paralysis. Nature. 2022 Nov;611(7936):540-547. doi: 10.1038/s41586-022-05385-7. Epub 2022 Nov 9.
    Results Reference
    background
    PubMed Identifier
    16304564
    Citation
    Claydon VE, Steeves JD, Krassioukov A. Orthostatic hypotension following spinal cord injury: understanding clinical pathophysiology. Spinal Cord. 2006 Jun;44(6):341-51. doi: 10.1038/sj.sc.3101855. Epub 2005 Nov 22.
    Results Reference
    background
    PubMed Identifier
    32690972
    Citation
    Skinnider MA, Squair JW, Kathe C, Anderson MA, Gautier M, Matson KJE, Milano M, Hutson TH, Barraud Q, Phillips AA, Foster LJ, La Manno G, Levine AJ, Courtine G. Cell type prioritization in single-cell data. Nat Biotechnol. 2021 Jan;39(1):30-34. doi: 10.1038/s41587-020-0605-1. Epub 2020 Jul 20.
    Results Reference
    background
    PubMed Identifier
    34172974
    Citation
    Squair JW, Skinnider MA, Gautier M, Foster LJ, Courtine G. Prioritization of cell types responsive to biological perturbations in single-cell data with Augur. Nat Protoc. 2021 Aug;16(8):3836-3873. doi: 10.1038/s41596-021-00561-x. Epub 2021 Jun 25.
    Results Reference
    background
    PubMed Identifier
    34584091
    Citation
    Squair JW, Gautier M, Kathe C, Anderson MA, James ND, Hutson TH, Hudelle R, Qaiser T, Matson KJE, Barraud Q, Levine AJ, La Manno G, Skinnider MA, Courtine G. Confronting false discoveries in single-cell differential expression. Nat Commun. 2021 Sep 28;12(1):5692. doi: 10.1038/s41467-021-25960-2.
    Results Reference
    background
    PubMed Identifier
    33328910
    Citation
    Gill M, Linde M, Fautsch K, Hale R, Lopez C, Veith D, Calvert J, Beck L, Garlanger K, Edgerton R, Sayenko D, Lavrov I, Thoreson A, Grahn P, Zhao K. Epidural Electrical Stimulation of the Lumbosacral Spinal Cord Improves Trunk Stability During Seated Reaching in Two Humans With Severe Thoracic Spinal Cord Injury. Front Syst Neurosci. 2020 Nov 19;14:79. doi: 10.3389/fnsys.2020.569337. eCollection 2020.
    Results Reference
    background
    PubMed Identifier
    24248345
    Citation
    Grindberg RV, Yee-Greenbaum JL, McConnell MJ, Novotny M, O'Shaughnessy AL, Lambert GM, Arauzo-Bravo MJ, Lee J, Fishman M, Robbins GE, Lin X, Venepally P, Badger JH, Galbraith DW, Gage FH, Lasken RS. RNA-sequencing from single nuclei. Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19802-7. doi: 10.1073/pnas.1319700110. Epub 2013 Nov 18.
    Results Reference
    background
    PubMed Identifier
    27339989
    Citation
    Lake BB, Ai R, Kaeser GE, Salathia NS, Yung YC, Liu R, Wildberg A, Gao D, Fung HL, Chen S, Vijayaraghavan R, Wong J, Chen A, Sheng X, Kaper F, Shen R, Ronaghi M, Fan JB, Wang W, Chun J, Zhang K. Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain. Science. 2016 Jun 24;352(6293):1586-90. doi: 10.1126/science.aaf1204.
    Results Reference
    background
    PubMed Identifier
    30948552
    Citation
    Maniatis S, Aijo T, Vickovic S, Braine C, Kang K, Mollbrink A, Fagegaltier D, Andrusivova Z, Saarenpaa S, Saiz-Castro G, Cuevas M, Watters A, Lundeberg J, Bonneau R, Phatnani H. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science. 2019 Apr 5;364(6435):89-93. doi: 10.1126/science.aav9776.
    Results Reference
    background
    PubMed Identifier
    27365449
    Citation
    Stahl PL, Salmen F, Vickovic S, Lundmark A, Navarro JF, Magnusson J, Giacomello S, Asp M, Westholm JO, Huss M, Mollbrink A, Linnarsson S, Codeluppi S, Borg A, Ponten F, Costea PI, Sahlen P, Mulder J, Bergmann O, Lundeberg J, Frisen J. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science. 2016 Jul 1;353(6294):78-82. doi: 10.1126/science.aaf2403.
    Results Reference
    background
    PubMed Identifier
    29556028
    Citation
    Asboth L, Friedli L, Beauparlant J, Martinez-Gonzalez C, Anil S, Rey E, Baud L, Pidpruzhnykova G, Anderson MA, Shkorbatova P, Batti L, Pages S, Kreider J, Schneider BL, Barraud Q, Courtine G. Cortico-reticulo-spinal circuit reorganization enables functional recovery after severe spinal cord contusion. Nat Neurosci. 2018 Apr;21(4):576-588. doi: 10.1038/s41593-018-0093-5. Epub 2018 Mar 19.
    Results Reference
    background
    PubMed Identifier
    28724575
    Citation
    Mignardot JB, Le Goff CG, van den Brand R, Capogrosso M, Fumeaux N, Vallery H, Anil S, Lanini J, Fodor I, Eberle G, Ijspeert A, Schurch B, Curt A, Carda S, Bloch J, von Zitzewitz J, Courtine G. A multidirectional gravity-assist algorithm that enhances locomotor control in patients with stroke or spinal cord injury. Sci Transl Med. 2017 Jul 19;9(399):eaah3621. doi: 10.1126/scitranslmed.aah3621.
    Results Reference
    background
    PubMed Identifier
    30382197
    Citation
    Wagner FB, Mignardot JB, Le Goff-Mignardot CG, Demesmaeker R, Komi S, Capogrosso M, Rowald A, Seanez I, Caban M, Pirondini E, Vat M, McCracken LA, Heimgartner R, Fodor I, Watrin A, Seguin P, Paoles E, Van Den Keybus K, Eberle G, Schurch B, Pralong E, Becce F, Prior J, Buse N, Buschman R, Neufeld E, Kuster N, Carda S, von Zitzewitz J, Delattre V, Denison T, Lambert H, Minassian K, Bloch J, Courtine G. Targeted neurotechnology restores walking in humans with spinal cord injury. Nature. 2018 Nov;563(7729):65-71. doi: 10.1038/s41586-018-0649-2. Epub 2018 Oct 31.
    Results Reference
    background
    PubMed Identifier
    22897489
    Citation
    Phillips AA, Krassioukov AV, Ainslie PN, Warburton DE. Baroreflex function after spinal cord injury. J Neurotrauma. 2012 Oct 10;29(15):2431-45. doi: 10.1089/neu.2012.2507. Epub 2012 Sep 20.
    Results Reference
    background
    PubMed Identifier
    35132264
    Citation
    Rowald A, Komi S, Demesmaeker R, Baaklini E, Hernandez-Charpak SD, Paoles E, Montanaro H, Cassara A, Becce F, Lloyd B, Newton T, Ravier J, Kinany N, D'Ercole M, Paley A, Hankov N, Varescon C, McCracken L, Vat M, Caban M, Watrin A, Jacquet C, Bole-Feysot L, Harte C, Lorach H, Galvez A, Tschopp M, Herrmann N, Wacker M, Geernaert L, Fodor I, Radevich V, Van Den Keybus K, Eberle G, Pralong E, Roulet M, Ledoux JB, Fornari E, Mandija S, Mattera L, Martuzzi R, Nazarian B, Benkler S, Callegari S, Greiner N, Fuhrer B, Froeling M, Buse N, Denison T, Buschman R, Wende C, Ganty D, Bakker J, Delattre V, Lambert H, Minassian K, van den Berg CAT, Kavounoudias A, Micera S, Van De Ville D, Barraud Q, Kurt E, Kuster N, Neufeld E, Capogrosso M, Asboth L, Wagner FB, Bloch J, Courtine G. Activity-dependent spinal cord neuromodulation rapidly restores trunk and leg motor functions after complete paralysis. Nat Med. 2022 Feb;28(2):260-271. doi: 10.1038/s41591-021-01663-5. Epub 2022 Feb 7.
    Results Reference
    background
    PubMed Identifier
    24305828
    Citation
    Capogrosso M, Wenger N, Raspopovic S, Musienko P, Beauparlant J, Bassi Luciani L, Courtine G, Micera S. A computational model for epidural electrical stimulation of spinal sensorimotor circuits. J Neurosci. 2013 Dec 4;33(49):19326-40. doi: 10.1523/JNEUROSCI.1688-13.2013.
    Results Reference
    background
    PubMed Identifier
    33469022
    Citation
    Greiner N, Barra B, Schiavone G, Lorach H, James N, Conti S, Kaeser M, Fallegger F, Borgognon S, Lacour S, Bloch J, Courtine G, Capogrosso M. Recruitment of upper-limb motoneurons with epidural electrical stimulation of the cervical spinal cord. Nat Commun. 2021 Jan 19;12(1):435. doi: 10.1038/s41467-020-20703-1.
    Results Reference
    background
    PubMed Identifier
    26853304
    Citation
    Moraud EM, Capogrosso M, Formento E, Wenger N, DiGiovanna J, Courtine G, Micera S. Mechanisms Underlying the Neuromodulation of Spinal Circuits for Correcting Gait and Balance Deficits after Spinal Cord Injury. Neuron. 2016 Feb 17;89(4):814-28. doi: 10.1016/j.neuron.2016.01.009. Epub 2016 Feb 4.
    Results Reference
    background
    PubMed Identifier
    22464657
    Citation
    Minassian K, Hofstoetter U, Tansey K, Mayr W. Neuromodulation of lower limb motor control in restorative neurology. Clin Neurol Neurosurg. 2012 Jun;114(5):489-97. doi: 10.1016/j.clineuro.2012.03.013. Epub 2012 Mar 29.
    Results Reference
    background

    Learn more about this trial

    Study on Preliminary Safety and Efficacy of the ARC Therapy Using the ARC-IM Lumbar System to Support Mobility in People With Chronic Spinal Cord Injury (BoxSwitch)

    We'll reach out to this number within 24 hrs